c.4393C>T (p.Arg1465X)
Variant ID | Exon |
59 | Exon 34 |
Domains | RNA effect |
CC X | RNA stability |
The reading frame is interrupted by a premature STOP codon.
The mRNA produced might be targeted for nonsense mediated decay (NMD).
Patient information | Allele 1 | Allele 2 | |||||||||||||||
Patient ID | Family ID | Gender | Age | Origin | Disease | Segregation | Parental consanguinity | Consanguinity degree | Exon/intron | Nucleotide nomencl. | Protein nomencl. | Detection method | Exon/intron | Nucleotide nomencl. | Protein nomencl. | Detection method | Reference |
MTI125 | female | 6 y | United States Of America | CORS | unknown | no | Exon 34 | 4393C>T | R1465X | DHPLC | Brancati (2007) | ||||||
MTI286 | female | 13 y | Brazil | CORS | unknown | no | Exon 34 | 4393C>T | R1465X | DHPLC | Brancati (2007) | ||||||
COR031 | female | 15 y | Belgium | CORS | unknown | yes | Exon 34 | 4393C>T | R1465X | DHPLC | Exon 36 | 4723A>T | K1575X | DHPLC | Brancati (2007) | ||
LCA-5 | LCA-5 | male | Belgium | LCA | unknown | no | Exon 34 | c.4393C>T | p.Arg1465X | Direct sequencing (Sanger) | Intron 26 | c.2991+1655A>G | p.Cys998X | Direct sequencing (Sanger) | |||
SLS-3 | SLS-3 | male | Belgium | SLS | unknown | no | Exon 34 | c.4393C>T | p.Arg1465X | Direct sequencing (Sanger) | Exon 36 | c.4723A>T | p.Lys1575X | Direct sequencing (Sanger) | |||
SLS-2 | SLS-2 | female | Belgium | SLS | unknown | no | Exon 34 | c.4393C>T | p.Arg1465X | Direct sequencing (Sanger) | Exon 36 | c.4723A>T | p.Lys1575X | Direct sequencing (Sanger) |